For instance, Das Thakur and colleagues argued that vemurafenib-resistant melanoma cells exhibit similar resistance to the MEK inhibitor AZD6244, due to elevated BRAF (V600E) expression 7. The gene discussed is MAP2K7; the disease is melanoma.